Not recruiting
EGFR gene mutation+2
Not recruitingPharmacokinetics, Bioavailability and Excretion of BAY 2927088 in Healthy Male Participants for Non‑Small Cell Lung Cancer
InvestigationalNo placebo
Pharmacokinetics, Bioavailability and Excretion of BAY 2927088 in Healthy Male Participants for Non‑Small Cell Lung Cancer
InvestigationalNo placebo
- Disease:EGFR gene mutationNon-small cell lung cancer+1
- Substances:Sevabertinib
Countries:
The Netherlands
The Netherlands- Participants:18–64 years · Healthy volunteers
- Substances:Sevabertinib
- Sponsor:Bayer AG
